MCID: PTT050
MIFTS: 47

Pituitary Adenoma, Growth Hormone-Secreting malady

Genetic diseases (common), Cancer diseases, Endocrine diseases categories

Aliases & Classifications for Pituitary Adenoma, Growth Hormone-Secreting

About this section

Aliases & Descriptions for Pituitary Adenoma, Growth Hormone-Secreting:

Name: Pituitary Adenoma, Growth Hormone-Secreting 49
Growth Hormone-Secreting Pituitary Adenoma 65 36
Somatotroph Adenoma 10 24
Growth Hormone Producing Adenoma of the Pituitary 10
Pituitary Adenoma, Growth Hormone-Secreting, 1 67
Growth Hormone Secreting Adenoma of Pituitary 10
Growth Hormone Secreting Pituitary Adenoma 10
Acromegaly Due to Pituitary Adenoma 1 67
Familial Isolated Pituitary Adenoma 67
Acromegaly Due to Pituitary Adenoma 67
 
Familial Isolated Somatotropinomas 67
Isolated Familial Somatotropinoma 67
Somatotrophinoma, Familial 65
Familial Somatotrophinoma 67
Acromegaly, Somatic 49
Pagh1 67
Fipa 67
Ifs 67
Fis 67


Classifications:



External Ids:

OMIM49 102200
Disease Ontology10 DOID:6255
SNOMED-CT59 254957009
NCIt42 C7461

Summaries for Pituitary Adenoma, Growth Hormone-Secreting

About this section
OMIM:49 Pituitary adenomas are benign monoclonal neoplasms of the anterior pituitary gland, accounting for approximately 15% of... (102200) more...

MalaCards based summary: Pituitary Adenoma, Growth Hormone-Secreting, also known as growth hormone-secreting pituitary adenoma, is related to pituitary gland disease and central nervous system primitive neuroectodermal neoplasm, and has symptoms including autosomal dominant inheritance, coarse facial features and hypertension. An important gene associated with Pituitary Adenoma, Growth Hormone-Secreting is AIP (Aryl Hydrocarbon Receptor Interacting Protein), and among its related pathways are G alpha (s) signalling events and Transcription_CREM signaling in testis. Affiliated tissues include pituitary, and related mouse phenotypes are adipose tissue and integument.

UniProtKB/Swiss-Prot:67 Pituitary adenoma, growth hormone-secreting, 1: A growth hormone-secreting, benign neoplasm of the anterior pituitary gland, also known as somatotropinoma. It clinically results in acromegaly, a condition characterized by coarse facial features, protruding jaw, and enlarged extremities. Excessive production of growth hormone in children or adolescents before the closure of epiphyses causes gigantism, a condition characterized by abnormally tall stature.

Related Diseases for Pituitary Adenoma, Growth Hormone-Secreting

About this section

Diseases in the Pituitary Adenoma, Growth Hormone-Secreting family:

Pituitary Adenoma, Growth Hormone-Secreting 2

Diseases related to Pituitary Adenoma, Growth Hormone-Secreting via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 1300)
idRelated DiseaseScoreTop Affiliating Genes
1pituitary gland disease31.0GNAS, SST
2central nervous system primitive neuroectodermal neoplasm30.5IGF1, PRL
3human immunodeficiency virus infectious disease30.5AIP, GNAS, IGF1, SST
4hypothyroidism30.3GHRH, PRL
5adrenal gland hyperfunction30.1AIP, GNAS, PRKAR1A, PRKAR1B, SST
6joint disorders30.0GAST, GHRH, IGF1, SST
7placenta disease29.9PRL, SST
8hypersensitivity reaction type ii disease29.9AIP, GHRH, IGF1, PRL, SST, SSTR5
9endocrine pancreas disease29.8AIP, GHRH, IGF1, PRL, SST
10spinal cord injury29.7GAST, GHRH, SST
11cell type cancer29.6AIP, GNAS, IGF1, PRL, SST, SSTR5
12postherpetic neuralgia29.6GNAS, IGF1, PRL, SST, SSTR5
13arteritic anterior ischemic optic neuropathy29.6GNAS, SST
14medullary thyroid carcinoma, familial29.5GAST, SST, SSTR5
15pituitary carcinoma29.2AIP, GHRH, GNAS, IGF1, PRKAR1A, PRL
16adenoma11.3
17pituitary adenoma11.3
18familial isolated pituitary adenoma11.0
19pituitary adenoma, growth hormone-secreting 210.7
20aip-related familial isolated pituitary adenomas10.6
21acromegaly10.6
22endotheliitis10.6
23pituitary tumors10.5
24pituitary adenoma, prolactin-secreting10.4
25multiple endocrine neoplasia10.4
26fecal incontinence10.4
27adult syndrome10.4
28insulin-like growth factor i10.4
29moyamoya disease10.4
30child syndrome10.4
31hypothalamic neoplasm10.4
32gangliocytoma10.4
33adrenal carcinoma10.4
34cushing's syndrome10.4
35fibrous dysplasia10.4
36malignant growth hormone secreting neoplasm of pituitary10.4
37adrenal cortical adenoma10.4
38aortitis10.4
39adenocarcinoma10.4
40adrenal adenoma10.4
41adrenal gland disease10.4
42brain cancer10.4
43central nervous system cancer10.4
44endocrine gland cancer10.4
45glucose metabolism disease10.4
46hypothalamic disease10.4
47lipomatosis10.4
48nervous system cancer10.4
49neuroendocrine tumor10.4
50supratentorial cancer10.4

Graphical network of the top 20 diseases related to Pituitary Adenoma, Growth Hormone-Secreting:



Diseases related to pituitary adenoma, growth hormone-secreting

Symptoms for Pituitary Adenoma, Growth Hormone-Secreting

About this section

Symptoms by clinical synopsis from OMIM:

102200

Clinical features from OMIM:

102200

HPO human phenotypes related to Pituitary Adenoma, Growth Hormone-Secreting:

(show all 14)
id Description Frequency HPO Source Accession
1 autosomal dominant inheritance HP:0000006
2 coarse facial features HP:0000280
3 hypertension HP:0000822
4 growth hormone excess HP:0000845
5 menstrual irregularities HP:0000858
6 prolactin excess HP:0000870
7 somatic mutation HP:0001428
8 cardiomyopathy HP:0001638
9 left ventricular hypertrophy HP:0001712
10 pituitary adenoma HP:0002893
11 pituitary prolactin cell adenoma HP:0006767
12 pituitary growth hormone cell adenoma HP:0011760
13 increased serum insulin-like growth factor 1 {comment="hpo HP:0030269
14 galactorrhea HP:0100829

Drugs & Therapeutics for Pituitary Adenoma, Growth Hormone-Secreting

About this section

Drugs for Pituitary Adenoma, Growth Hormone-Secreting (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Octreotideapproved, investigationalPhase 4, Phase 219183150-76-9383414, 6400441
Synonyms:
(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
79517-01-4 (acetate salt)
83150-76-9
AC1L1GVU
AC1L8LCD
AC1L9M4X
C07306
C5H12O2.C4H10
CHEBI:427278
CHEBI:611465
CHEMBL1680
CID383414
CID448601
CID54374
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide
D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide
D00442
DRG-0115
HMS2090C09
HS-2020
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*
L000453
 
LS-177735
LS-187135
Longastatin
NCGC00181796-01
NCI60_025753
Ocphyl
Octreotida
Octreotida [Spanish]
Octreotide
Octreotide (USAN/INN)
Octreotide Acetate
Octreotide Acetate Salt
Octreotide [USAN:INN:BAN]
Octreotide acetate
Octreotide-LAR
Octreotidum
Octreotidum [Latin]
Octrotide
SAN 201-995
SM 201-995
SMS 201-995
SMS-201-995
Sandostatin
Sandostatine
Sandoz 201-995
UNII-RWM8CCW8GP
nchembio.184-comp3
zacycloicosane-4-carboxamide acetate
2
Dexamethasoneapproved, investigationalPhase 1180650-02-25743
Synonyms:
(3H)-Dexamethasone
.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol
.gamma.corten
1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone
1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone
1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone
1-Dehydro-16α-methyl-9α-fluorohydrocortisone
137098-19-2
16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol
16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone
16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone
16-alpha-Methyl-9-alpha-fluoroprednisolone
16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol
16.alpha.-Methyl-9.alpha.-fluoroprednisolone
16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol
16alpha -Methyl-9alpha -fluoroprednisolone
16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol
16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone
16alpha-Methyl-9alpha-fluoroprednisolone
16α-Methyl-9α-fluoro-1-dehydrocortisol
23495-06-9
31375_FLUKA
46165_FLUKA
46165_RIEDEL
50-02-2
8054-59-9
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione
9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione
9-Fluoro-16-methylprednisolone
9-alpha-Fluoro-16-alpha-methylprednisolone
9.alpha.-Fluoro-16.alpha.-methylprednisolone
906422-84-2
9A-FLUORO-16BETA-METHYLPREDNISOLONE
9alpha -Fluoro-16alpha -methylprednisolone
9alpha-Fluoro-16alpha-methylprednisolone
9alpha-fluoro-16alpha-methyl-Prednisolone
9α-Fluoro-16α-methylprednisolone
AC-11056
AC1L1L1H
AC1Q29DM
AI3-50934
Adexone
Aeroseb-D
Aeroseb-Dex
Aeroseb-dex
Ak Dex Oph Otic Soln 0.1%
Alcon Brand of Dexamethasone
Anaflogistico
Aphtasolon
Aphthasolone
Apo-dexamethasone
Auxiron
Azimycin (veterinary)
Azium
Azium (Veterinary)
Azium (veterinary)
BIDD:ER0494
BIDD:PXR0060
BRD-K38775274-001-02-3
BRD-K38775274-001-06-4
BSPBio_000995
Baycadron
Bisu DS
Bisu Ds
C15643
C22H29FO5
CCRIS 7067
CHEBI:41879
CHEMBL384467
CID5743
CPD-10549
CPD001227192
Calonat
Corson
Corsone
Cortisumman
D00292
D003907
D1756_SIGMA
D4902_SIGMA
D6645_SIGMA
D8893_SIGMA
D9184_SIGMA
DB01234
DEX
DEXA
DEXONE 0.5
DEXONE 0.75
DEXONE 1.5
DEXONE 4
DXM
DXMS
Decacort
Decacortin
Decaderm
Decadron
Decadron (TN)
Decadron Tablets, Elixir
Decadron, Dexamethasone
Decadron-LA
Decadron-La
Decagel
Decaject
Decaject L.A.
Decaject-L.A.
Decalix
Decameth
Decasone
Decaspray
Dectancyl
Dekacort
Delta1-9alpha-Fluoro-16alpha-methylcortisol
Deltafluorene
Dergramin
Deronil
Desadrene
Desametasone
Desametasone [DCIT]
Desametasone [Dcit]
Desamethasone
Desameton
Deseronil
Dex-Ide
Dex-ide
Dexa
Dexa Mamallet
Dexa mamallet
Dexa-Cortidelt
Dexa-Cortisyl
Dexa-Mamallet
Dexa-Scheroson
Dexa-Sine
Dexa-cortidelt
Dexa-cortisyl
Dexa-scheroson
Dexa-sine
Dexacen-4
Dexacidin
Dexacort
Dexacortal
Dexacortin
Dexadeltone
Dexafarma
Dexair
Dexalona
Dexaltin
Dexametasona
Dexametasona [INN-Spanish]
Dexametasone
Dexameth
Dexamethansone
 
Dexamethasone
Dexamethasone (JP15/USP/INN)
Dexamethasone Acetate
Dexamethasone Alcohol
Dexamethasone Base
Dexamethasone Intensol
Dexamethasone Sodium Phosphate
Dexamethasone [INN:BAN:JAN]
Dexamethasone acetate
Dexamethasone alcohol
Dexamethasone base
Dexamethasone intensol
Dexamethasone sodium phosphate
Dexamethasone-omega
Dexamethasonum
Dexamethasonum [INN-Latin]
Dexamethazone
Dexamethsone
Dexamonozon
Dexapolcort
Dexapos
Dexaprol
Dexason
Dexasone
Dexasone 0.5mg
Dexasone 0.75mg
Dexasone 4mg
Dexasporin
Dexinolon
Dexinoral
Dexone
Dexone 0.5
Dexone 0.75
Dexone 1.5
Dexone 4
Dexonium
Dexpak
Dextelan
Dezone
Dinormon
Dxms
ECR Brand of Dexamethasone
EINECS 200-003-9
FT-0080377
Fluormethylprednisolone
Fluormone
Fluorocort
Fortecortin
Foy Brand of Dexamethasone
Gammacorten
HL-dex
HMS1792A17
HMS1990A17
HMS2089N13
HSDB 3053
Hexadecadrol
Hexadrol
Hexadrol Elixir
Hexadrol Tablets
Hexadrol elixir
Hl-Dex
Hl-dex
I06-1196
ICN Brand of Dexamethasone
IontoDex
Isopto-Dex
Isopto-dex
LS-7300
Lokalison F
Lokalison f
Loverine
Luxazone
MK 125
MLS001055412
MLS001332507
MLS001332508
Maxidex
Maxidex Ont 0.1%
Maxidex Sus 0.1%
Maxitrol
Mediamethasone
Merck Brand of Dexamethasone
Merz Brand 1 of Dexamethasone
Merz Brand 2 of Dexamethasone
Methylfluorprednisolone
Mexidex
Millicorten
MolMap_000018
MolPort-003-846-433
Mymethasone
NCGC00091019-01
NCGC00091019-02
NCGC00091019-03
NCGC00091019-04
NCGC00091019-05
NCI60_003067
NSC 34521
NSC34521
Naquasone (veterinary)
Neomycin and polymyxin b sulfates and dexamethasone
Neomycin and polymyxin b sulphates and dexamethasone
OTO-104
Ocu-Trol
Ocu-trol
Oradexon
Ozurdex
PHL-dexamethasone
PMS-dexamethasone
Pet Derm III
Pet Derm Iii
Pet derm III
Pet-Derm Iii
Pms Dexamethasone Elixir 0.5mg/5ml
Policort
Posurdex
Prednisolon F
Prednisolon f
Prednisolone F
Prednisolone f
Prodex
S1322_Selleck
SAM002548948
SGCUT00126
SK-Dexamethasone
SK-dexamethasone
SMP1_000092
SMR000857119
SMR001227192
ST50307091
Sandoz dexamethasone
Sk-Dexamethasone
Spectrum5_002019
Spoloven
Sunia Sol D
Sunia sol D
Superprednol
TL8003317
Tobradex
Tobramycin and dexamethasone
Tresaderm (veterinary)
Turbinaire
UNII-7S5I7G3JQL
Visumetazone
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1
ZINC03875332
alpha -Fluoro-16-alpha -methylcortisol
delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol
delta1-9alpha-Fluoro-16alpha-methylcortisol
dexamethasone
nchembio809-comp2
to_000038
3Dexamethasone acetatePhase 118061177-87-3
4Dexamethasone 21-phosphatePhase 11806
5BB 1101Phase 11848

Interventional clinical trials:

idNameStatusNCT IDPhase
1Preoperative Octreotide Treatment of AcromegalyCompletedNCT00521300Phase 4
2An Extension Study to Assess the Long-term Safety and Efficacy of Pasireotide in Patients With AcromegalyCompletedNCT00171730Phase 2
3Temozolomide in Treating Patients With Invasive Pituitary TumorsWithdrawnNCT00601289Phase 2
4Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell LeukemiaTerminatedNCT01088763Phase 1
5Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome SubjectsRecruitingNCT02574793
6Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education ToolsRecruitingNCT01775332
7Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPARecruitingNCT00461188
8Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in AcromegalyRecruitingNCT01902420

Search NIH Clinical Center for Pituitary Adenoma, Growth Hormone-Secreting


Cochrane evidence based reviews: Growth Hormone-Secreting Pituitary Adenoma

Genetic Tests for Pituitary Adenoma, Growth Hormone-Secreting

About this section

Genetic tests related to Pituitary Adenoma, Growth Hormone-Secreting:

id Genetic test Affiliating Genes
1 Somatotroph Adenoma24

Anatomical Context for Pituitary Adenoma, Growth Hormone-Secreting

About this section

MalaCards organs/tissues related to Pituitary Adenoma, Growth Hormone-Secreting:

33
Pituitary

Animal Models for Pituitary Adenoma, Growth Hormone-Secreting or affiliated genes

About this section

MGI Mouse Phenotypes related to Pituitary Adenoma, Growth Hormone-Secreting:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053758.9GHRHR, GHSR, GNAS, IGF1, PRKAR1A
2MP:00107718.2AIP, GHRHR, GNAS, IGF1, PRKAR1B, PRL
3MP:00053787.1AIP, GHRH, GHRHR, GHSR, GNAS, IGF1
4MP:00053796.7AIP, GAST, GHRH, GHRHR, GNAS, IGF1
5MP:00053876.3GAST, GHRH, GHRHR, GNAS, IGF1, PRKAR1A
6MP:00053766.0AIP, GAST, GHRH, GHRHR, GHSR, GNAS

Publications for Pituitary Adenoma, Growth Hormone-Secreting

About this section

Variations for Pituitary Adenoma, Growth Hormone-Secreting

About this section

Clinvar genetic disease variations for Pituitary Adenoma, Growth Hormone-Secreting:

5 (show all 59)
id Gene Variation Type Significance SNP ID Assembly Location
1GNASNM_000516.5(GNAS): c.601C> T (p.Arg201Cys)single nucleotide variantPathogenicrs11554273GRCh37Chr 20, 57484420: 57484420
2GNASNM_000516.5(GNAS): c.602G> A (p.Arg201His)single nucleotide variantPathogenicrs121913495GRCh37Chr 20, 57484421: 57484421
3GNASNM_000516.5(GNAS): c.680A> G (p.Gln227Arg)single nucleotide variantPathogenicrs121913494GRCh37Chr 20, 57484596: 57484596
4GNASNM_000516.5(GNAS): c.601C> A (p.Arg201Ser)single nucleotide variantPathogenicrs11554273GRCh37Chr 20, 57484420: 57484420
5AIPNM_003977.2(AIP): c.-1212_279+578deldeletionLikely pathogenicGRCh37Chr 11, 67249418: 67255234
6AIPNM_003977.2(AIP): c.(?_1)_(*_?)deletionLikely pathogenic
7AIPNM_003977.3(AIP): c.100-1025_279+357del1562deletionLikely pathogenicGRCh37Chr 11, 67253452: 67255013
8AIPNM_003977.3(AIP): c.138_161del24 (p.Gly47_Arg54del)deletionLikely pathogenicrs267606537GRCh37Chr 11, 67254515: 67254538
9AIPNM_003977.3(AIP): c.166C> A (p.Arg56Ser)single nucleotide variantLikely pathogenicrs267606538GRCh37Chr 11, 67254543: 67254543
10AIPNM_003977.3(AIP): c.174G> C (p.Lys58Asn)single nucleotide variantLikely pathogenicrs267606539GRCh37Chr 11, 67254551: 67254551
11AIPNM_003977.3(AIP): c.241C> T (p.Arg81Ter)single nucleotide variantPathogenicrs267606541GRCh37Chr 11, 67254618: 67254618
12AIPNM_003977.3(AIP): c.244_248delGAAGG (p.Glu82Glyfs)deletionLikely pathogenicrs267606542GRCh37Chr 11, 67254621: 67254625
13AIPNM_003977.3(AIP): c.249G> T (p.Gly83=)single nucleotide variantLikely pathogenicrs104895072GRCh37Chr 11, 67254626: 67254626
14AIPNM_003977.3(AIP): c.250G> A (p.Glu84Lys)single nucleotide variantLikely pathogenicrs267606543GRCh37Chr 11, 67254627: 67254627
15AIPNM_003977.3(AIP): c.280-1G> Asingle nucleotide variantLikely pathogenicrs267606544GRCh37Chr 11, 67256737: 67256737
16AIPNM_003977.3(AIP): c.286_287delGT (p.Val96Profs)deletionLikely pathogenicrs267606545GRCh37Chr 11, 67256744: 67256745
17AIPNM_003977.3(AIP): c.2T> C (p.Met1Thr)single nucleotide variantLikely pathogenicrs267606546GRCh37Chr 11, 67250631: 67250631
18AIPNM_003977.3(AIP): c.308A> G (p.Lys103Arg)single nucleotide variantLikely pathogenicrs267606548GRCh37Chr 11, 67256766: 67256766
19AIPNM_003977.3(AIP): c.350delG (p.Gly117Alafs)deletionLikely pathogenicrs267606549GRCh37Chr 11, 67256808: 67256808
20AIPNM_003977.3(AIP): c.3_4insC (p.Ala2Argfs)insertionLikely pathogenicrs267606547GRCh37Chr 11, 67250632: 67250633
21AIPNM_003977.3(AIP): c.404delA (p.His135Leufs)deletionLikely pathogenicrs267606551GRCh37Chr 11, 67256862: 67256862
22AIPNM_003977.3(AIP): c.424C> T (p.Gln142Ter)single nucleotide variantLikely pathogenicrs267606552GRCh37Chr 11, 67256882: 67256882
23AIPNM_003977.3(AIP): c.468+1G> Asingle nucleotide variantLikely pathogenicrs267606554GRCh37Chr 11, 67256927: 67256927
24AIPNM_003977.3(AIP): c.469-2A> Gsingle nucleotide variantLikely pathogenicrs267606556GRCh37Chr 11, 67257507: 67257507
25AIPNM_003977.3(AIP): c.490C> T (p.Gln164Ter)single nucleotide variantLikely pathogenicrs104895073GRCh37Chr 11, 67257530: 67257530
26AIPNM_003977.3(AIP): c.500delC (p.Pro167Hisfs)deletionLikely pathogenicrs267606557GRCh37Chr 11, 67257540: 67257540
27AIPNM_003977.3(AIP): c.517_521delGAAGA (p.Glu174Glyfs)deletionLikely pathogenicrs267606558GRCh37Chr 11, 67257557: 67257561
28AIPNM_003977.3(AIP): c.550C> T (p.Gln184Ter)single nucleotide variantLikely pathogenicrs267606560GRCh37Chr 11, 67257590: 67257590
29AIPNM_003977.3(AIP): c.584T> C (p.Val195Ala)single nucleotide variantLikely pathogenicrs267606561GRCh37Chr 11, 67257624: 67257624
30AIPNM_003977.3(AIP): c.591G> A (p.Glu197=)single nucleotide variantLikely pathogenicrs202006716GRCh37Chr 11, 67257631: 67257631
31AIPNM_003977.3(AIP): c.601A> T (p.Lys201Ter)single nucleotide variantLikely pathogenicrs267606563GRCh37Chr 11, 67257641: 67257641
32AIPNM_003977.3(AIP): c.646G> T (p.Glu216Ter)single nucleotide variantLikely pathogenicrs267606565GRCh37Chr 11, 67257787: 67257787
33AIPNM_003977.3(AIP): c.649C> T (p.Gln217Ter)single nucleotide variantLikely pathogenicrs267606566GRCh37Chr 11, 67257790: 67257790
34AIPNM_003977.3(AIP): c.662dupC (p.Glu222Terfs)duplicationLikely pathogenicrs104895075GRCh37Chr 11, 67257803: 67257803
35AIPNM_003977.3(AIP): c.70G> T (p.Glu24Ter)single nucleotide variantLikely pathogenicrs267606568GRCh37Chr 11, 67250699: 67250699
36AIPNM_003977.3(AIP): c.713G> A (p.Cys238Tyr)single nucleotide variantLikely pathogenicrs267606569GRCh37Chr 11, 67257854: 67257854
37AIPNM_003977.3(AIP): c.715C> T (p.Gln239Ter)single nucleotide variantLikely pathogenicrs267606571GRCh37Chr 11, 67257856: 67257856
38AIPNM_003977.3(AIP): c.721A> G (p.Lys241Glu)single nucleotide variantPathogenicrs267606573GRCh37Chr 11, 67257862: 67257862
39AIPNM_003977.3(AIP): c.721A> T (p.Lys241Ter)single nucleotide variantLikely pathogenicrs267606573GRCh37Chr 11, 67257862: 67257862
40AIPNM_003977.3(AIP): c.742_744delTAC (p.Tyr248del)deletionLikely pathogenicrs267606574GRCh37Chr 11, 67257883: 67257885
41AIPNM_003977.3(AIP): c.74_81delTCCCGGACins7indelLikely pathogenicrs104895074GRCh37Chr 11, 67250703: 67250710
42AIPNM_003977.3(AIP): c.769A> G (p.Ile257Val)single nucleotide variantLikely pathogenicrs267606575GRCh37Chr 11, 67257910: 67257910
43AIPNM_003977.3(AIP): c.803A> G (p.Tyr268Cys)single nucleotide variantLikely pathogenicrs267606577GRCh37Chr 11, 67258274: 67258274
44AIPNM_003977.3(AIP)duplicationPathogenicrs267606578GRCh37Chr 11, 67258276: 67258296
45AIPNM_003977.3(AIP): c.807C> T (p.Phe269=)single nucleotide variantPathogenicrs139407567GRCh37Chr 11, 67258278: 67258278
46AIPNM_003977.3(AIP): c.811C> T (p.Arg271Trp)single nucleotide variantPathogenicrs267606579GRCh37Chr 11, 67258282: 67258282
47AIPNM_003977.3(AIP): c.829G> C (p.Ala277Pro)single nucleotide variantLikely pathogenicrs267606581GRCh37Chr 11, 67258300: 67258300
48AIPNM_003977.3(AIP): c.854_857delAGGC (p.Gln285Leufs)deletionLikely pathogenicrs267606582GRCh37Chr 11, 67258325: 67258328
49AIPNM_003977.3(AIP): c.919dupC (p.Arg307Profs)duplicationLikely pathogenicrs267606589GRCh37Chr 11, 67258390: 67258390
50AIPNM_003977.3(AIP): c.-125-95G> Asingle nucleotide variantLikely pathogenicrs267606540GRCh37Chr 11, 67250410: 67250410
51AIPNM_003977.3(AIP): c.880_891delCTGGACCCAGCC (p.Asp295_Leu298del)deletionLikely pathogenicrs267606585GRCh37Chr 11, 67258351: 67258362
52AIPNM_003977.3(AIP): c.40C> T (p.Gln14Ter)single nucleotide variantPathogenicrs104894194GRCh37Chr 11, 67250669: 67250669
53AIPNM_003977.3(AIP): c.469-1G> Asingle nucleotide variantLikely pathogenic, Pathogenicrs267606555GRCh37Chr 11, 67257508: 67257508
54AIPNM_003977.3(AIP): c.910C> T (p.Arg304Ter)single nucleotide variantPathogenicrs104894195GRCh37Chr 11, 67258381: 67258381
55AIPNM_003977.3(AIP): c.66_71delAGGAGA (p.Gly23_Glu24del)deletionLikely pathogenic, Pathogenicrs267606567GRCh37Chr 11, 67250695: 67250700
56AIPNM_003977.3(AIP): c.824dupA (p.His275Glnfs)duplicationLikely pathogenic, Pathogenicrs267606580GRCh37Chr 11, 67258295: 67258295
57AIPNM_003977.3(AIP): c.542delT (p.Ile182Serfs)deletionLikely pathogenic, Pathogenicrs267606559GRCh37Chr 11, 67257582: 67257582
58AIPNM_003977.3(AIP): c.804C> A (p.Tyr268Ter)single nucleotide variantLikely pathogenic, Pathogenicrs121908356GRCh37Chr 11, 67258275: 67258275
59AIPNM_003977.3(AIP): c.64C> T (p.Arg22Ter)single nucleotide variantLikely pathogenic, Pathogenicrs121908357GRCh37Chr 11, 67250693: 67250693

Cosmic variations for Pituitary Adenoma, Growth Hormone-Secreting:

7
id Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Conf
127899GNASpituitary,NS,adenoma,GH3
227889GNASpituitary,NS,adenoma,GH3
349087GNASpituitary,NS,adenoma,GH3
427895GNASpituitary,NS,adenoma,GH3
527893GNASpituitary,NS,adenoma,GH3
627887GNASpituitary,NS,adenoma,GH3
7483HRASpituitary,NS,adenoma,GH3

Expression for genes affiliated with Pituitary Adenoma, Growth Hormone-Secreting

About this section
Search GEO for disease gene expression data for Pituitary Adenoma, Growth Hormone-Secreting.

Pathways for genes affiliated with Pituitary Adenoma, Growth Hormone-Secreting

About this section

Pathways related to Pituitary Adenoma, Growth Hormone-Secreting according to GeneCards Suite gene sharing:

(show all 14)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.2GHRH, GHRHR, GNAS, TSHB
28.8GNAS, PRKAR1A, PRKAR1B
38.8GNAS, PRKAR1A, PRKAR1B
4
Show member pathways
8.8GNAS, PRKAR1A, PRKAR1B
58.8GNAS, PRKAR1A, PRKAR1B
6
Show member pathways
8.8GNAS, PRKAR1A, PRKAR1B
78.7PRKAR1A, PRKAR1B, TNFAIP3
88.6PRKAR1A, PRKAR1B, TSPO
9
Show member pathways
8.6GNAS, IGF1, PRKAR1A, PRKAR1B
10
Show member pathways
8.6GNAS, IGF1, PRKAR1A, PRKAR1B
11
Show member pathways
8.3GHRH, GHRHR, GNAS, PRKAR1A, PRKAR1B
12
Show member pathways
8.2GHRH, IGF1, PRKAR1A, PRKAR1B, TNFAIP3
13
Show member pathways
7.4GHRH, GHRHR, GHSR, GNAS, PRL, SST
14
Show member pathways
5.3GAST, GHRH, GHRHR, GHSR, GNAS, IGF1

GO Terms for genes affiliated with Pituitary Adenoma, Growth Hormone-Secreting

About this section

Cellular components related to Pituitary Adenoma, Growth Hormone-Secreting according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cAMP-dependent protein kinase complexGO:00059529.6PRKAR1A, PRKAR1B
2extracellular regionGO:00055768.1GAST, GHRH, GNAS, IGF1, PRL, SST

Biological processes related to Pituitary Adenoma, Growth Hormone-Secreting according to GeneCards Suite gene sharing:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1adenylate cyclase-activating adrenergic receptor signaling pathwayGO:007188010.7GNAS, GPR101
2positive regulation of hormone secretionGO:004688710.6GHRH, GHRHR
3adenohypophysis developmentGO:002198410.6GHRH, GHRHR
4water homeostasisGO:003010410.6GHRHR, IGF1
5positive regulation of growth hormone secretionGO:006012410.5GHRH, GHRHR
6negative regulation of interleukin-1 beta productionGO:003269110.3GHSR, TNFAIP3
7growth hormone secretionGO:003025210.3GHRH, GHRHR, GHSR
8regulation of protein metabolic processGO:005124610.3GHRHR, IGF1
9adenylate cyclase-activating G-protein coupled receptor signaling pathwayGO:000718910.2GHRH, GHRHR, GNAS
10positive regulation of cAMP biosynthetic processGO:003081910.2GHRH, GHRHR, GNAS
11positive regulation of insulin-like growth factor receptor signaling pathwayGO:004356810.1GHRH, GHRHR, GHSR, IGF1
12positive regulation of multicellular organism growthGO:004001810.0GHRH, GHRHR, GHSR
13response to foodGO:00320949.8GAST, GHRH, GHSR
14activation of protein kinase A activityGO:00341999.7PRKAR1A, PRKAR1B
15negative regulation of cAMP-dependent protein kinase activityGO:20004809.7PRKAR1A, PRKAR1B
16cell-cell signalingGO:00072679.6GHRH, GPR101, SST, TSHB
17cell surface receptor signaling pathwayGO:00071669.5GHRHR, PRL, SST, TNFAIP3
18renal water homeostasisGO:00030919.4GNAS, PRKAR1A, PRKAR1B
19water transportGO:00068339.4GNAS, PRKAR1A, PRKAR1B
20regulation of protein phosphorylationGO:00019329.4IGF1, PRKAR1A, PRKAR1B
21energy reserve metabolic processGO:00061129.3GNAS, PRKAR1A, PRKAR1B
22cellular response to glucagon stimulusGO:00713779.2GNAS, PRKAR1A, PRKAR1B
23regulation of insulin secretionGO:00507968.8GNAS, PRKAR1A, PRKAR1B, SSTR5
24G-protein coupled receptor signaling pathwayGO:00071867.7GAST, GHRHR, GHSR, GNAS, GPR101, SST
25signal transductionGO:00071657.3AIP, GAST, GHRHR, GNAS, IGF1, PRKAR1A

Molecular functions related to Pituitary Adenoma, Growth Hormone-Secreting according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1insulin-like growth factor receptor bindingGO:000515910.3GNAS, IGF1
2growth hormone-releasing hormone receptor activityGO:001652010.2GHRHR, GHSR
3cAMP-dependent protein kinase inhibitor activityGO:00048629.5PRKAR1A, PRKAR1B
4protein kinase A catalytic subunit bindingGO:00342369.4PRKAR1A, PRKAR1B
5cAMP-dependent protein kinase regulator activityGO:00086039.4PRKAR1A, PRKAR1B
6cAMP bindingGO:00305529.4PRKAR1A, PRKAR1B
7hormone activityGO:00051798.4GAST, GHRH, IGF1, PRL, SST, TSHB

Sources for Pituitary Adenoma, Growth Hormone-Secreting

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet